Empagliflozin, an SGLT2 inhibitor, reduced the mortality...

  • Main
  • 2018 / 12
  • Empagliflozin, an SGLT2 inhibitor, reduced the mortality...

Empagliflozin, an SGLT2 inhibitor, reduced the mortality rate after acute myocardial infarction with modification of cardiac metabolomes and anti-oxidants in diabetic rats.

Oshima, Hiroto, Miki, Takayuki, Kuno, Atsushi, Mizuno, Masashi, Sato, Tatsuya, Tanno, Masaya, Yano, Toshiyuki, Nakata, Kei, Kimura, Yukishige, Abe, Koki, Ohwada, Wataru, Miura, Tetsuji
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Journal of Pharmacology and Experimental Therapeutics
DOI:
10.1124/jpet.118.253666
Date:
December, 2018
File:
PDF, 1.61 MB
english, 2018
Conversion to is in progress
Conversion to is failed